181 related articles for article (PubMed ID: 37294663)
21. Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery for patients with locally advanced rectal cancer: a systematic review and meta-analysis.
Feng S; Yan P; Zhang Q; Li Z; Li C; Geng Y; Wang L; Zhao X; Yang Z; Cai H; Wang X
Int J Colorectal Dis; 2020 Aug; 35(8):1355-1369. PubMed ID: 32488419
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
23. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
25. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
[TBL] [Abstract][Full Text] [Related]
26. Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial.
Vidal J; Casadevall D; Bellosillo B; Pericay C; Garcia-Carbonero R; Losa F; Layos L; Alonso V; Capdevila J; Gallego J; Vera R; Salud A; Martin-Richard M; Nogué M; Cillán E; Maurel J; Faull I; Raymond V; Fernández-Martos C; Montagut C
Clin Cancer Res; 2021 May; 27(10):2890-2898. PubMed ID: 33727257
[TBL] [Abstract][Full Text] [Related]
27. Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study.
Huang X; Zheng Z; Zeng B; Xiao H; Zheng H; Lin Z; Song J; Li A; Chi P; Yang Y; Xu B; Zheng R
BMC Cancer; 2023 Mar; 23(1):238. PubMed ID: 36918865
[TBL] [Abstract][Full Text] [Related]
28. Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer.
McDuff SGR; Hardiman KM; Ulintz PJ; Parikh AR; Zheng H; Kim DW; Lennerz JK; Hazar-Rethinam M; Van Seventer EE; Fetter IJ; Nadres B; Eyler CE; Ryan DP; Weekes CD; Clark JW; Cusack JC; Goyal L; Zhu AX; Wo JY; Blaszkowsky LS; Allen J; Corcoran RB; Hong TS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250394
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Ho SSK; Hon SSF; Hung E; Lee JFY; Mo F; Tong M; So C; Chu S; Ng DCK; Lam D; Cho C; Mak TWC; Ng SSM; Futaba K; Suen J; To KF; Chan AWH; Yeung WWK; Ma BBY
Hong Kong Med J; 2022 Jun; 28(3):230-238. PubMed ID: 35667869
[TBL] [Abstract][Full Text] [Related]
30. Worse prognosis in young patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A comparative study.
Zhang Y; Wang Y; Liu X; Chen B; Zhuang J; Li S; Yang Y; Su Y; Guan G
Medicine (Baltimore); 2020 Aug; 99(35):e21304. PubMed ID: 32871861
[TBL] [Abstract][Full Text] [Related]
31. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
32. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
[No Abstract] [Full Text] [Related]
34. Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer.
Silva VSE; Abdallah EA; Flores BCT; Braun AC; Costa DJF; Ruano APC; Gasparini VA; Silva MLG; Mendes GG; Claro LCL; Calsavara VF; Aguiar Junior S; de Mello CAL; Chinen LTD
Cells; 2021 Jun; 10(6):. PubMed ID: 34207124
[TBL] [Abstract][Full Text] [Related]
35. Prolonged interval to surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis of randomized controlled trials.
Owens PW; Saeed M; McCawley N; Loughlin P; Kearney DE; Burke JP; McNamara DA; Sahebally SM
Surgeon; 2024 Jun; 22(3):166-173. PubMed ID: 38521683
[TBL] [Abstract][Full Text] [Related]
36. MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer.
Khakoo S; Carter PD; Brown G; Valeri N; Picchia S; Bali MA; Shaikh R; Jones T; Begum R; Rana I; Wotherspoon A; Terlizzo M; von Loga K; Kalaitzaki E; Saffery C; Watkins D; Tait D; Chau I; Starling N; Hubank M; Cunningham D
Clin Cancer Res; 2020 Jan; 26(1):183-192. PubMed ID: 31852830
[TBL] [Abstract][Full Text] [Related]
37. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
38. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.
Zhu K; Zhao Q; Yue J; Shi P; Yan H; Xu X; Wang R
Oncotarget; 2016 Oct; 7(42):68328-68338. PubMed ID: 27634904
[TBL] [Abstract][Full Text] [Related]
39. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
40. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
